PubMed

Recurrence of choroidal neovascularisation after photodynamic therapy in patients with age-related macular degeneration.

Potter MJ, Szabo SM.

Br J Ophthalmol. 2007 Jun;91(6):753-6. Epub 2007 Jan 17.PMID: 17229805 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.

Arch Ophthalmol. 1999 Sep;117(9):1177-87. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10496389 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

[No authors listed]

Arch Ophthalmol. 1999 Oct;117(10):1329-45. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10532441 [PubMed - indexed for MEDLINE]Related articles

Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.

Voelker M, Gelisken F, Ziemssen F, Wachtlin J, Grisanti S.

Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1241-6. Epub 2005 Jul 12.PMID: 16010552 [PubMed - indexed for MEDLINE]Related articles

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.

Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS.

Br J Ophthalmol. 2006 Mar;90(3):337-41.PMID: 16488958 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Verteporfin In Photodynamic Therapy Study Group.

Am J Ophthalmol. 2001 May;131(5):541-60.PMID: 11336929 [PubMed - indexed for MEDLINE]Related articles

Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.

Chaudhary V, Mao A, Hooper PL, Sheidow TG.

Ophthalmology. 2007 Dec;114(12):2183-9.PMID: 18054638 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.

Essex RW, Qureshi SH, Cain MS, Harper CA, Guymer RH.

Clin Experiment Ophthalmol. 2003 Dec;31(6):476-81.PMID: 14641153 [PubMed - indexed for MEDLINE]Related articles

Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

Spaide RF, Sorenson J, Maranan L.

Ophthalmology. 2003 Aug;110(8):1517-25.PMID: 12917166 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Arch Ophthalmol. 2002 Nov;120(11):1443-54.PMID: 12427056 [PubMed - indexed for MEDLINE]Related articles

Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.

Blinder KJ, Bradley S, Bressler NM, Bressler SB, Donati G, Hao Y, Ma C, Menchini U, Miller J, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Strong HA, Stur M, Su XY, Virgili G; Treatment of Age-related Macular Degeneration with Photodynamic Therapy study group; Verteporfin in Photodynamic Therapy study group.

Am J Ophthalmol. 2003 Sep;136(3):407-18.PMID: 12967792 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.

Sharp DM, Lai S, Markey CM.

Clin Experiment Ophthalmol. 2007 Jan-Feb;35(1):24-31.PMID: 17300567 [PubMed - indexed for MEDLINE]Related articles

Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.

Nicolò M, Ghiglione D, Lai S, Nasciuti F, Cicinelli S, Calabria G.

Retina. 2006 Jan;26(1):58-64.PMID: 16395140 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.

Ladd BS, Solomon SD, Bressler NM, Bressler SB.

Am J Ophthalmol. 2001 Nov;132(5):659-67.PMID: 11704027 [PubMed - indexed for MEDLINE]Related articles

Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

Lüke M, Ziemssen F, Völker M, Altpeter E, Beutel J, Besch D, Bartz-Schmidt KU, Gelisken F.

Graefes Arch Clin Exp Ophthalmol. 2009 Jun;247(6):745-54. Epub 2009 Feb 12.PMID: 19214552 [PubMed - indexed for MEDLINE]Related articles

One-year outcomes after photodynamic therapy in patients with age-related macular degeneration with poor baseline visual acuity.

Potter MJ, Szabo SM.

Graefes Arch Clin Exp Ophthalmol. 2006 Aug;244(8):1026-8. Epub 2005 Dec 8.PMID: 16341540 [PubMed - indexed for MEDLINE]Related articles

One-year results of photodynamic therapy for small predominantly classic choroidal neovascular membranes secondary to age-related macular degeneration.

Doyle E, Khanwala M, Shah SP, Ong DG, Casswell AG.

Eur J Ophthalmol. 2007 Sep-Oct;17(5):760-7.PMID: 17932852 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with delayed light application for the treatment of bilateral subfoveal choroidal neovascularization in age-related macular degeneration.

Karacorlu M, Karacorlu S, Ozdemir H.

Jpn J Ophthalmol. 2003 Nov-Dec;47(6):595-8.PMID: 14636851 [PubMed - indexed for MEDLINE]Related articles

Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.

Kaiser PK; Registry of Visudyne AMD Therapy Writing Committee, Boyer DS, Garcia R, Hao Y, Hughes MS, Jabbour NM, Kaiser PK, Mieler W, Slakter JS, Samuel M, Tolentino MJ, Roth D, Sheidow T, Strong HA.

Ophthalmology. 2009 Apr;116(4):747-55, 755.e1. Epub 2009 Feb 25.PMID: 19243834 [PubMed - indexed for MEDLINE]Related articles